MicroRNAs in skeletal muscle: Their role and regulation in development, disease and function
Open accessAbstract
Maintaining skeletal muscle function throughout the lifespan is a prerequisite for good health and independent living. For skeletal muscle to consistently function at optimal levels, the efficient activation of processes that regulate muscle development, growth, regeneration and metabolism is required. Numerous conditions including neuromuscular disorders, physical inactivity, chronic disease and ageing are associated with perturbations in skeletal muscle function. A loss or reduction in skeletal muscle function often leads to increased morbidity and mortality either directly, or indirectly, via the development of secondary diseases such as diabetes, obesity, cardiovascular and respiratory disease. Identifying mechanisms which influence the processes regulating skeletal muscle function is a key priority. The discovery of microRNAs (miRNAs) provides a new avenue that will extend our knowledge of factors controlling skeletal muscle function. miRNAs may also improve our understanding and application of current therapeutic approaches as well as enable the identification of new therapeutic strategies and targets aimed at maintaining and/or improving skeletal muscle health. This review brings together the latest developments in skeletal muscle miRNA biology and focuses on their role and regulation under physiological and patho-physiological conditions with an emphasis on: myogenesis, hypertrophy, atrophy and regeneration; exercise and nutrition; muscle disease, ageing, diabetes and obesity.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Muscle-enriched miRNAs such as miR-1 and miR-133a have been implicated in control of growth-related pathways and may modulate translation of genes involved in ribosomal assembly or myogenic adaptation.
“Muscle-enriched miRNAs such as miR-1 and miR-133a have been implicated in the control of growth-related pathways and may modulate the translation of genes involved in ribosomal assembly or myogenic adaptation [198,199].”
From Ribosome Biogenesis as a Putative Bottleneck to Skeletal Muscle Hypertrophy: Mechanisms, Human Evidence, and Practical Modulators (2026) · cites this paper as [199]
The sections on muscle-enriched miRNAs and skeletal muscle hypertrophy identify miR-1 and miR-133a and discuss their potential regulation of growth-related targets. The paper also describes miRNA-mediated repression of protein translation, including miR-1 inhibition of myostatin translation. The passages do not link these miRNAs to translation of genes involved in ribosomal assembly; no page numbers are available in our copy. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 105 · Cited by 290
- Authors
- Güller, I., & Russell, A. P.
- Affiliations
- Deakin University (AU)
- ORCID
- Russell, Aaron P.
- Venue
- The Journal of Physiology
- Publisher
- Wiley
- Published
- 2010-10-29
- Volume
- 588
- Issue
- 21
- Pages
- 4075-4087
- ISSN
- 0022-3751 (ISSN-L)
- PMC
- PMC3002442
- OpenAlex
- W1913987579
- Cited by
- 290
- References
- 105
- Citations by year
- 2026: 10 · 2025: 12 · 2024: 18 · 2023: 16 · 2022: 24 · 2021: 31 · 2020: 22 · 2019: 24 · 2018: 9 · 2017: 19 · 2016: 27 · 2015: 20 · 2014: 16 · 2013: 17 · 2012: 17
- FWCI
- 1.17
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Physiology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Deakin Research Online (Deakin University) (submittedVersion)
- Funders
- Deakin University
- Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- microRNA, skeletal muscle, myogenesis, muscle hypertrophy, muscle atrophy, muscle regeneration, physical activity, nutrition, neuromuscular disorders, aging, diabetes mellitus, obesity, muscle metabolism, therapeutic target
- MeSH terms
- Aging, Animals, Diabetes Mellitus, Humans, Musculoskeletal Diseases, Exercise, Muscle, Skeletal, Muscle Development, MicroRNAs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review